Pregafree 1.5mg Tablet

Introduction

Pregafree is a prescription medication that contains the active ingredient Levonorgestrel. It is commonly known by its generic name and does not have any brand name(s) associated with it. Levonorgestrel is a synthetic hormone that belongs to the class of medications called progestins.

Uses

Pregafree is primarily used as an emergency contraceptive, commonly referred to as the “morning-after pill.” It is used to prevent pregnancy when taken within 72 hours (3 days) after unprotected intercourse or contraceptive failure. It is not intended for regular contraceptive use and should not be relied upon as a primary method of birth control.

Dosage and Administration

The recommended dosage for Pregafree is one tablet, taken orally, as soon as possible after unprotected intercourse or contraceptive failure. It is most effective when taken within 24 hours. However, it can still be effective up to 72 hours (3 days) after intercourse. If vomiting occurs within 2 hours of taking the tablet, a healthcare professional should be consulted, as an additional dose may be necessary.

Mechanism of Action

Levonorgestrel works by preventing or delaying ovulation, the release of an egg from the ovary. It may also alter the cervical mucus and the lining of the uterus, making it more difficult for sperm to reach the egg and for a fertilized egg to implant in the uterus.

Side Effects

Common side effects of Pregafree may include nausea, vomiting, abdominal pain, fatigue, headache, and breast tenderness. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult a healthcare professional.

Serious side effects are rare, but they may include severe abdominal pain, persistent vomiting, severe dizziness, chest pain, shortness of breath, severe headache, or vision changes. If any of these serious side effects occur, immediate medical attention should be sought.

Drug Interactions

Pregafree may interact with certain medications, including certain antifungal medications, anticonvulsants, and herbal supplements such as St. John’s wort. Inform your healthcare professional about all medications, supplements, and herbal products you are taking before using Pregafree to avoid potential interactions.

Precautions

Pregafree should not be used if you are already pregnant, as it is not effective in terminating an existing pregnancy. It is also not intended for use in individuals with known or suspected allergy to levonorgestrel or any other ingredients in the tablet.

Note that Pregafree does not protect against sexually transmitted infections (STIs). If there is a risk of STIs, additional protective measures should be taken.

Storage

Patient Tips

• Pregafree is most effective when taken as soon as possible after unprotected intercourse or contraceptive failure.
• If you experience vomiting within 2 hours of taking the tablet, consult a healthcare professional, as an additional dose may be needed.
• If your menstrual period is more than a week late or significantly lighter or heavier than usual after taking Pregafree, consult a healthcare professional to rule out pregnancy.
• Remember that Pregafree does not protect against sexually transmitted infections. Additional protective measures should be taken if there is a risk of STIs.
• If you have any concerns or questions about Pregafree, consult your healthcare professional for guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Benilexa One Handed 20 micrograms/24 hours Intrauterine Delivery System (Health Professionals SmPC) Available at:
• Levonorgestrel intrauterine system (Drugs.com) [Accessed 29 Jun. 2024] (online) Available at:
• estradiol-levonorgestrel patch, transdermal weekly (RX) [Accessed 3 Jun. 2024] (online) Available at:
• Levonorgestrel Intrauterine System (MedlinePlus) [Accessed 22 Jun. 2024] (online) Available at:
• Fotherby K. Levonorgestrel. Clinical pharmacokinetics. Clin Pharmacokinet. 1995 Mar;28(3):203-15. doi: 10.2165/00003088-199528030-00003. [Accessed 11 Jun. 2024] Available at: